DexCom, Inc. - stock earnings
DXCM Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| April 25, 2024 AfterMarket | 0.32 / 0.28 | - | - / 927.4 million | - |
| May 22, 2024 AfterMarket | - / - | 877.7 million | - / 909.2 million | 928.0 million |
| July 25, 2024 BeforeMarket | - / - | 1.0 billion | - / 1.0 billion | 1.1 billion |
DXCM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | 146.4 million USD | 921.0 million USD |
| 2023Q4 | 256.3 million USD | 1.0 billion USD |
| 2023Q3 | 120.7 million USD | 975.0 million USD |
| 2023Q2 | 115.9 million USD | 871.3 million USD |
| 2023Q1 | 48.6 million USD | 741.5 million USD |
| 2022Q4 | 91.8 million USD | 815.2 million USD |
| 2022Q3 | 101.2 million USD | 769.6 million USD |
| 2022Q2 | 50.9 million USD | 696.2 million USD |
| 2022Q1 | 97.3 million USD | 628.8 million USD |
| 2021Q4 | -19.4 million USD | 698.2 million USD |
| 2021Q3 | 70.9 million USD | 650.2 million USD |
| 2021Q2 | 62.9 million USD | 595.1 million USD |
| 2021Q1 | 40.3 million USD | 505.0 million USD |
| 2020Q4 | 355.2 million USD | 568.9 million USD |
| 2020Q3 | 72.2 million USD | 500.9 million USD |
| 2020Q2 | 46.3 million USD | 451.8 million USD |
| 2020Q1 | 19.9 million USD | 405.1 million USD |
| 2019Q4 | 92.7 million USD | 462.8 million USD |
| 2019Q3 | 45.8 million USD | 396.3 million USD |
| 2019Q2 | -10.5 million USD | 336.4 million USD |
| 2019Q1 | -26.9 million USD | 280.5 million USD |
| 2018Q4 | -179.7 million USD | 338.0 million USD |
| 2018Q3 | 46.6 million USD | 266.7 million USD |
| 2018Q2 | 30.2 million USD | 242.5 million USD |
| 2018Q1 | -24.2 million USD | 184.4 million USD |
| 2017Q4 | -9.4 million USD | 221.0 million USD |
| 2017Q3 | -2.0 million USD | 184.6 million USD |
| 2017Q2 | 2.9 million USD | 170.6 million USD |
| 2017Q1 | -41.7 million USD | 142.3 million USD |
| 2016Q4 | -7.4 million USD | 171.2 million USD |
| 2016Q3 | -18.8 million USD | 148.6 million USD |
| 2016Q2 | -20.2 million USD | 137.3 million USD |
| 2016Q1 | -19.2 million USD | 116.2 million USD |
| 2015Q4 | 1.5 million USD | 130.8 million USD |
| 2015Q3 | -42.5 million USD | 105.2 million USD |
| 2015Q2 | -3.7 million USD | 93.2 million USD |
| 2015Q1 | -12.9 million USD | 72.8 million USD |
| 2014Q4 | 1.3 million USD | 84.3 million USD |
| 2014Q3 | -5.2 million USD | 69.0 million USD |
| 2014Q2 | -6.0 million USD | 58.8 million USD |
| 2014Q1 | -12.5 million USD | 47.1 million USD |
| 2013Q4 | -2.6 million USD | 51.7 million USD |
| 2013Q3 | -6.0 million USD | 42.9 million USD |
| 2013Q2 | -10.1 million USD | 35.8 million USD |
| 2013Q1 | -11.1 million USD | 29.6 million USD |
| 2012Q4 | -8.5 million USD | 33.3 million USD |
| 2012Q3 | -17.3 million USD | 23.1 million USD |
| 2012Q2 | -14.7 million USD | 23.5 million USD |
| 2012Q1 | -14.1 million USD | 20.1 million USD |
| 2011Q4 | -12.3 million USD | 22.4 million USD |
| 2011Q3 | -13.3 million USD | 18.3 million USD |
| 2011Q2 | -7.4 million USD | 21.4 million USD |
| 2011Q1 | -11.9 million USD | 14.2 million USD |
| 2010Q4 | -9.8 million USD | 15.6 million USD |
| 2010Q3 | -13.4 million USD | 11.7 million USD |
| 2010Q2 | -11.7 million USD | 11.8 million USD |
| 2010Q1 | -20.3 million USD | 9.5 million USD |
| 2009Q4 | -11.5 million USD | 10.5 million USD |
| 2009Q3 | -13.5 million USD | 7.3 million USD |
| 2009Q2 | -15.3 million USD | 6.8 million USD |
| 2009Q1 | -13.1 million USD | 5.2 million USD |
| 2008Q4 | -13.5 million USD | 4.1 million USD |
| 2008Q3 | -14.7 million USD | 1.9 million USD |
| 2008Q2 | -14.1 million USD | 2.0 million USD |
| 2008Q1 | -13.0 million USD | 1.9 million USD |
| 2007Q4 | -12.2 million USD | 1.5 million USD |
| 2007Q3 | -11.4 million USD | 1.2 million USD |
| 2007Q2 | -11.3 million USD | 863000 USD |
| 2007Q1 | -10.9 million USD | 1.0 million USD |
| 2006Q4 | -11.1 million USD | 834917 USD |
| 2006Q3 | -13.4 million USD | 841020 USD |
| 2006Q2 | -11.2 million USD | 479078 USD |
| 2006Q1 | -10.9 million USD | 14775 USD |
| 2005Q4 | -12.1 million USD | ? USD |
| 2005Q3 | -6.3 million USD | ? USD |
| 2005Q2 | -6.4 million USD | ? USD |
| 2005Q1 | -6.0 million USD | ? USD |
| 2004Q4 | ? USD | ? USD |
| 2004Q3 | ? USD | ? USD |
| 2004Q2 | ? USD | ? USD |
| 2004Q1 | ? USD | ? USD |
| 2003Q4 | ? USD | ? USD |
DXCM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 541.5 million USD | 3.6 billion USD |
| 2022 | 341.2 million USD | 2.9 billion USD |
| 2021 | 154.7 million USD | 2.4 billion USD |
| 2020 | 493.6 million USD | 1.9 billion USD |
| 2019 | 101.1 million USD | 1.5 billion USD |
| 2018 | -127.1 million USD | 1.0 billion USD |
| 2017 | -50.2 million USD | 718.5 million USD |
| 2016 | -65.6 million USD | 573.3 million USD |
| 2015 | -57.6 million USD | 402.0 million USD |
| 2014 | -22.4 million USD | 259.2 million USD |
| 2013 | -29.8 million USD | 160.0 million USD |
| 2012 | -54.5 million USD | 99.9 million USD |
| 2011 | -44.7 million USD | 76.3 million USD |
| 2010 | -55.2 million USD | 48.6 million USD |
| 2009 | -53.5 million USD | 29.7 million USD |
| 2008 | -55.2 million USD | 9.8 million USD |
| 2007 | -45.9 million USD | 4.6 million USD |
| 2006 | -46.6 million USD | 2.2 million USD |
| 2005 | -30.8 million USD | ? USD |
| 2004 | -13.9 million USD | ? USD |
| 2003 | -9.9 million USD | ? USD |
| 2002 | -7.7 million USD | ? USD |
| 2001 | -6.3 million USD | ? USD |
| 2000 | -4.0 million USD | ? USD |
DXCM
Price: $124.34
52 week price:
Earnings Per Share: 1.29 USD
P/E Ratio: 139.13
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Volume: 3.0 million
Ebitda: 6.3 millionMarket Capitalization: 49.4 billion